Corteva, Inc. (CTVA)
| Market Cap | 50.85B +5.6% |
| Revenue (ttm) | 17.81B +3.7% |
| Net Income | 1.01B -28.0% |
| EPS | 1.50 -26.4% |
| Shares Out | 667.20M |
| PE Ratio | 47.35 |
| Forward PE | 19.29 |
| Dividend | $0.72 (0.94%) |
| Ex-Dividend Date | Sep 1, 2026 |
| Volume | 3,592,925 |
| Open | 76.14 |
| Previous Close | 76.47 |
| Day's Range | 75.59 - 76.95 |
| 52-Week Range | 60.54 - 90.97 |
| Beta | 0.57 |
| Analysts | Buy |
| Price Target | 92.40 (+21.23%) |
| Earnings Date | Jul 30, 2026 |
About CTVA
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profit... [Read more]
Financial Performance
In 2025, Corteva's revenue was $17.40 billion, an increase of 2.92% compared to the previous year's $16.91 billion. Earnings were $1.09 billion, an increase of 20.62%.
Financial StatementsAnalyst Summary
According to 21 analysts, the average rating for CTVA stock is "Buy." The 12-month stock price target is $92.4, which is an increase of 21.23% from the latest price.
News
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval
A federal judge on Friday approved more than $2.5 billion of settlements that New Jersey reached with DuPont , Chemours , Corteva and 3M to resolve claims over pollution attributed to PFAS, also know...
Corteva Announces Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
INDIANAPOLIS, Aug. 6, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announced today that Vylor Inc., a Delaware corporation and its wholly owned subsidiary ("Vylor"), has commenced private offers to...
Corteva price target raised to $101 from $100 at Deutsche Bank
Deutsche Bank analyst David Begleiter raised the firm’s price target on Corteva (CTVA) to $101 from $100 and keeps a Buy rating on the shares.
Corteva price target raised to $89 from $86 at UBS
UBS analyst Joshua Spector raised the firm’s price target on Corteva (CTVA) to $89 from $86.
Corteva price target raised to $83 from $77 at JPMorgan
JPMorgan raised the firm’s price target on Corteva (CTVA) to $83 from $77 and keeps a Neutral rating on the shares.
Corteva price target raised to $100 from $95 at BMO Capital
BMO Capital analyst Joel Jackson raised the firm’s price target on Corteva (CTVA) to $100 from $95 and keeps an Outperform rating on the shares. The market’s negative reaction to…
Corteva price target raised to $86 from $85 at Citi
Citi raised the firm’s price target on Corteva (CTVA) to $86 from $85 and keeps a Neutral rating on the shares.
Corteva Earnings Call Transcript: Q2 2026
Strong first-half 2026 results with 4% sales and 10% EBITDA growth led to raised full-year guidance. Both seed and crop protection segments showed resilience, with margin expansion and robust technology adoption. Separation into two companies remains on track for October 1.
Corteva Slides: Q2 2026
Corteva has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 31, 2026.
Corteva Earnings release: Q2 2026
Corteva released its Q2 2026 earnings on July 31, 2026, summarizing the period's financial results.
Corteva Quarterly report: Q2 2026
Corteva has published its Q2 2026 quarterly earnings report on July 31, 2026.
Corteva remains on-track to complete planned separation
Chuck Magro, Chief Executive Officer: “Our strong first half was fueled by demand for next-gen Seed technologies, differentiated Crop Protection products, and focused execution. This level of performa...
Corteva reports Q2 adjusted EPS $2.30, consensus $2.23
Reports Q2 revenue $6.38B, consensus $6.6B.
Corteva raises FY26 operating EPS view to $3.60-$3.80 from $3.45-$3.70
FY26 consensus $3.76. Raises FY26 operating EBITDA view to $4.1B-$4.3B from $4B-$4.2B. “Strong demand remains the defining feature of the agricultural landscape, supporting overall fundamentals across...
Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation
Seed 1H results reflect continued value capture on latest in-demand germplasm and trait technologies, including licensing growth Crop Protection 1H demand for new products and focus on operational exc...
Corteva Declares Quarterly Dividend
INDIANAPOLIS, July 24, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced its Board of Directors has authorized a common stock dividend of $0.18 cents per share, payable September 15, 202...
Corteva price target raised to $103 from $97 at RBC Capital
RBC Capital analyst Arun Viswanathan raised the firm’s price target on Corteva (CTVA) to $103 from $97 and keeps an Outperform rating on the shares as part of a broader…
Corteva price target raised to $96 from $90 at BofA
BofA raised the firm’s price target on Corteva (CTVA) to $96 from $90 and keeps a Buy rating on the shares. The firm is adjusting estimates to reflect a volatile…
Corteva price target raised to $97 from $96 at Mizuho
Mizuho raised the firm’s price target on Corteva (CTVA) to $97 from $96 and keeps an Outperform rating on the shares. The firm adjusted targets in the chemicals group as…
NY AG sues 3M, Corteva, DuPont over toxic pollution from consumer products
New York Attorney General Letitia James sued some of the nation’s largest chemical and agricultural companies – 3M Company (MMM), EIDP, The Chemours Company (CC), Corteva, Inc. (CTVA), and DuPont…
Corteva and Arevo Partner on Soy Crop Nutrition
The partnership will help farmers in Europe improve nutrient use efficiency The partnership will help farmers in Europe improve nutrient use efficiency
Corteva price target raised to $96 from $94 at Mizuho
Mizuho raised the firm’s price target on Corteva (CTVA) to $96 from $94 and keeps an Outperform rating on the shares following a review of the company’s SEC filing for…
Corteva Announces Board of Directors for Future Crop Protection Company
Greg Page to be Chair; separation on track for 4Q 2026 INDIANAPOLIS, June 29, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today its intended board of directors as a standalone publicly-tr...
Corteva Announces Board of Directors for Advanced Seed and Genetics Spin-Off Vylor
Karen Grimes to be Chair; separation on track for 4Q 2026 INDIANAPOLIS, June 29, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today the board of directors for Vylor Inc., the future public...
Corteva Transcript: Wolfe Research 3rd Annual Materials of the Future Conference 2026
EU approval of gene editing marks a major regulatory shift, enabling new crop technologies and global market expansion. Proprietary innovation, AI-driven breeding, and hybrid wheat are set to drive growth, while the spin-off structure enhances strategic focus and financial performance.